Publications by authors named "Vincent Strout"

Claim this Profile
C
Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis.
Jaroslaw Kierkus, Marina Pesegova, Maria Klopocka, Marija Brankovic, Noriyuki Kasai, Vincent Strout

Crohns Colitis 360· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis.
Jaroslaw Kierkus, Marina Pesegova, Maria Klopocka, Marija Brankovic, Noriyuki Kasai, Vincent Strout

Crohns Colitis 360· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors.
Monica M Mita, John Nemunaitis, Juneko Grilley-Olson, Bassil El-Rayes, Tanios Bekaii-Saab, Vincent Strout

Target Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma.
Rachid C Baz, Jeffrey A Zonder, Cristina Gasparetto, Frederic J Reu, Vincent Strout

Oncol Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
John Sarantopoulos, Monica M Mita, Michael J Birrer, Lee D Cranmer, Luis T Campos, Vincent Strout

Target Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis